Literature DB >> 25713345

Conformation and dynamics of the Gag polyprotein of the human immunodeficiency virus 1 studied by NMR spectroscopy.

Lalit Deshmukh1, Rodolfo Ghirlando2, G Marius Clore3.   

Abstract

Assembly and maturation of the human immunodeficiency virus type 1 (HIV-1) are governed by the Gag polyprotein. Here we study the conformation and dynamics of a large HIV-1 Gag fragment comprising the matrix, capsid, spacer peptide 1 and nucleocapsid domains (referred to as ΔGag) by heteronuclear multidimensional NMR spectroscopy. In solution, ΔGag exists in a dynamic equilibrium between monomeric and dimeric states. In the presence of nucleic acids and at low ionic strength ΔGag assembles into immature virus-like particles. The structured domains of ΔGag (matrix, the N- and C-terminal domains of capsid, and the N- and C-terminal zinc knuckles of nucleocapsid) retain their fold and reorient semi-independently of one another; the linkers connecting the structural domains, including spacer peptide 1 that connects capsid to nucleocapsid, are intrinsically disordered. Structural changes in ΔGag upon proteolytic processing by HIV-1 protease, monitored by NMR in real-time, demonstrate that the conformational transition of the N-terminal 13 residues of capsid from an intrinsically disordered coil to a β-hairpin upon cleavage at the matrix|capsid junction occurs five times faster than cleavage at the capsid|spacer peptide 1 junction. Finally, nucleic acids interact with both nucleocapsid and matrix domains, and proteolytic processing at the spacer peptide 1|nucleocapsid junction by HIV-1 protease is accelerated in the presence of single-stranded DNA.

Entities:  

Keywords:  HIV-1 Gag; interdomain motion; proteolytic processing; real time NMR; residual dipolar couplings

Mesh:

Substances:

Year:  2015        PMID: 25713345      PMCID: PMC4371905          DOI: 10.1073/pnas.1501985112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Evaluation of uncertainty in alignment tensors obtained from dipolar couplings.

Authors:  Markus Zweckstetter; Ad Bax
Journal:  J Biomol NMR       Date:  2002-06       Impact factor: 2.835

2.  Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy.

Authors:  Tanmay A M Bharat; Norman E Davey; Pavel Ulbrich; James D Riches; Alex de Marco; Michaela Rumlova; Carsten Sachse; Tomas Ruml; John A G Briggs
Journal:  Nature       Date:  2012-07-19       Impact factor: 49.962

Review 3.  Weak alignment NMR: a hawk-eyed view of biomolecular structure.

Authors:  Ad Bax; Alexander Grishaev
Journal:  Curr Opin Struct Biol       Date:  2005-10       Impact factor: 6.809

4.  Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides.

Authors:  R J Fisher; A Rein; M Fivash; M A Urbaneja; J R Casas-Finet; M Medaglia; L E Henderson
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Complete nucleotide sequence of the AIDS virus, HTLV-III.

Authors:  L Ratner; W Haseltine; R Patarca; K J Livak; B Starcich; S F Josephs; E R Doran; J A Rafalski; E A Whitehorn; K Baumeister
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

6.  Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain.

Authors:  Vineela Chukkapalli; Seung J Oh; Akira Ono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

7.  Discovery and structural characterization of a new inhibitor series of HIV-1 nucleocapsid function: NMR solution structure determination of a ternary complex involving a 2:1 inhibitor/NC stoichiometry.

Authors:  Nathalie Goudreau; Oliver Hucke; Anne-Marie Faucher; Chantal Grand-Maître; Olivier Lepage; Pierre R Bonneau; Stephen W Mason; Steve Titolo
Journal:  J Mol Biol       Date:  2013-02-26       Impact factor: 5.469

8.  Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly.

Authors:  C P Hill; D Worthylake; D P Bancroft; A M Christensen; W I Sundquist
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

9.  Structural basis of the association of HIV-1 matrix protein with DNA.

Authors:  Mengli Cai; Ying Huang; Robert Craigie; G Marius Clore
Journal:  PLoS One       Date:  2010-12-23       Impact factor: 3.240

10.  The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles.

Authors:  Albert T Nguyen; Christa L Feasley; Ken W Jackson; Theodore J Nitz; Karl Salzwedel; Gillian M Air; Michael Sakalian
Journal:  Retrovirology       Date:  2011-12-07       Impact factor: 4.602

View more
  27 in total

1.  Transient HIV-1 Gag-protease interactions revealed by paramagnetic NMR suggest origins of compensatory drug resistance mutations.

Authors:  Lalit Deshmukh; John M Louis; Rodolfo Ghirlando; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

2.  Solution Conformation of Bovine Leukemia Virus Gag Suggests an Elongated Structure.

Authors:  Dominic F Qualley; Sarah E Cooper; James L Ross; Erik D Olson; William A Cantara; Karin Musier-Forsyth
Journal:  J Mol Biol       Date:  2019-02-04       Impact factor: 5.469

3.  Major Variations in HIV-1 Capsid Assembly Morphologies Involve Minor Variations in Molecular Structures of Structurally Ordered Protein Segments.

Authors:  Jun-Xia Lu; Marvin J Bayro; Robert Tycko
Journal:  J Biol Chem       Date:  2016-04-19       Impact factor: 5.157

4.  Dynamic Nuclear Polarization Magic-Angle Spinning Nuclear Magnetic Resonance Combined with Molecular Dynamics Simulations Permits Detection of Order and Disorder in Viral Assemblies.

Authors:  Rupal Gupta; Huilan Zhang; Manman Lu; Guangjin Hou; Marc Caporini; Melanie Rosay; Werner Maas; Jochem Struppe; Jinwoo Ahn; In-Ja L Byeon; Hartmut Oschkinat; Kristaps Jaudzems; Emeline Barbet-Massin; Lyndon Emsley; Guido Pintacuda; Anne Lesage; Angela M Gronenborn; Tatyana Polenova
Journal:  J Phys Chem B       Date:  2019-06-11       Impact factor: 2.991

5.  Immature HIV-1 lattice assembly dynamics are regulated by scaffolding from nucleic acid and the plasma membrane.

Authors:  Alexander J Pak; John M A Grime; Prabuddha Sengupta; Antony K Chen; Aleksander E P Durumeric; Anand Srivastava; Mark Yeager; John A G Briggs; Jennifer Lippincott-Schwartz; Gregory A Voth
Journal:  Proc Natl Acad Sci U S A       Date:  2017-11-07       Impact factor: 11.205

6.  Binding kinetics and substrate selectivity in HIV-1 protease-Gag interactions probed at atomic resolution by chemical exchange NMR.

Authors:  Lalit Deshmukh; Vitali Tugarinov; John M Louis; G Marius Clore
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

7.  HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.

Authors:  Marc Potempa; Sook-Kyung Lee; Nese Kurt Yilmaz; Ellen A Nalivaika; Amy Rogers; Ean Spielvogel; Charles W Carter; Celia A Schiffer; Ronald Swanstrom
Journal:  J Mol Biol       Date:  2018-11-07       Impact factor: 5.469

8.  Nucleic acid-induced dimerization of HIV-1 Gag protein.

Authors:  Huaying Zhao; Siddhartha A K Datta; Sung H Kim; Samuel C To; Sumit K Chaturvedi; Alan Rein; Peter Schuck
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

9.  Proline-rich domain of human ALIX contains multiple TSG101-UEV interaction sites and forms phosphorylation-mediated reversible amyloids.

Authors:  Ruben D Elias; Wen Ma; Rodolfo Ghirlando; Charles D Schwieters; Vijay S Reddy; Lalit Deshmukh
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

10.  The Structure of Immature Virus-Like Rous Sarcoma Virus Gag Particles Reveals a Structural Role for the p10 Domain in Assembly.

Authors:  Florian K M Schur; Robert A Dick; Wim J H Hagen; Volker M Vogt; John A G Briggs
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.